✅ Suggested content. Review the technical data and compliance, adjust whatever you need and delete this line before publishing.
CJC-1295 DAC is an analog of GHRH (growth hormone-releasing factor) modified with a Drug Affinity Complex (DAC), which markedly prolongs its persistence in the body. It is studied in growth axis research. NeoPeptidos offers it with ≥99% HPLC purity, for research use.
Technical profile
| Product | CJC-1295 DAC |
|---|---|
| CAS | 863288-34-0 |
| Molecular formula | C₁₅₂H₂₅₂N₄₄O₄₂ |
| Molecular weight | 3647.96 Da |
| Sequence | Y(d-A)DAIFTQSYRKVLAQLSARKLLQDILSR-Lys(MPA)-NH₂ (30 aa) |
| Purity | 99% HPLC |
| Presentation | Lyophilized vial; bacteriostatic water included |
| Use | For scientific research use only |
What is CJC-1295 DAC?
The DAC allows the peptide to bind reversibly to albumin, extending its half-life from minutes to several days. This distinguishes it from short-acting GHRH analogs and makes it useful as a tool for studying sustained growth hormone release.
Research context
Research with CJC-1295 DAC lies in the study of the GHRH–GH axis and growth hormone release patterns in experimental models.
The NeoPeptidos product is research-grade material; it includes no indications or administration schedules and is intended exclusively for researchers.
Handling and reconstitution
See the reconstitution guide and the storage guide.
Quality and traceability
≥99% purity by HPLC and batch COA. See quality control.
🔬 Updated on July 15, 2026 · Reviewed by the NeoPeptidos team · Content for research purposes (RUO).